Access Industries' Access Biotechnology unit has contributed to a series A round for the paediatric oncology drug developer.

Stanford’s proteomic analysis spinout has lifted its funding haul beyond $100m with a round set to drive new hires and technology development.

Oxford Nanopore has added $59.6m to its latest funding round to bring the round to $98.1m and its overall funding to nearly $692m.

M12 returned in a $25m second close for the API marketplace provider having led the first tranche of the series B round last year.

The Dropbox-backed software management platform developer has now raised approximately $187m to date, Warburg Pincus leading its latest round.

Lendingkart has boosted its series D round to $41.3m, taking $11.3m in an extension featuring Bertelsmann India Investments and Sistema Asia Fund.

Pfizer, Lundbeckfonden Ventures and Biomed Ventures have all taken part in a round for the anti-infective therapy developer that has now passed $90m.

Tencent and Unilever Ventures have participated in a series B round for the business accounting platform developer, reportedly valuing it at up to $300m.

The corporate-backed health management service raised the cash from Perceptive Advisors and has used $30m to buy musculoskeletal-focused Physera.

Guangzhou Honest Dairy's yoghurt brand has spun off with $56.3m in a round led by Matrix Partners China that will fund the strengthening of its production resources.